← Eichor
Study identifier: NCT07592585 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Phase III Clinical Study of VC005 in Adult and Adolescents With Mild to Moderate Atopic Dermatitis

Condition: Atopic Dermatitis  ·  Sponsor: Jiangsu vcare pharmaceutical technology co., LTD

PhasePhase 3
Planned participants360
Who can joinAll sexes, 12 Years to no upper limit
Healthy volunteersNo

About this study

A multicenter, randomized, double-blind, vehicle controlled phase III clinical study to evaluate the efficacy and safety of VC005 in adults and adolescents with mild to moderate atopic dermatitis

This description comes directly from the study's public registry record.

Talk to the study team

xiaojuan lai  ·  +8615358160458  ·  lai_xiaojuan@vcarepharmatech.com

Always discuss trial participation with your own doctor first.

Locations (1)

Chinese Academy of Medical Sciences Hospital for Skin DiseaseNanjing, Jiangsu, ChinaRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07592585